港股開盤 | 三大指數高開,疫苗、有色金屬板塊領漲
【三大指數】
恆生指數開盤漲166.34點,漲幅0.58%,報28776.99點;
國企指數開盤漲67.39點,漲幅0.63%,報10766.39點;
恆生科技指數開盤漲32.53點,漲幅0.41%,報7987.35點。
【異動板塊】
疫苗醫藥股強勢拉漲,有色金屬板塊走強,有色礦業漲超6%,鋼鐵股走高,重慶鋼鐵漲超4%;
體育用品板塊走弱,特步跌超1%。
【異動個股】
復星醫藥大漲14.99%,公告稱,控股子公司復星醫藥產業擬與BioNTech投資設立合資公司,以實現mRNA新冠疫苗產品的本地化生產及商業化。
國藥控股大漲超7%,當地時間7日,世衛將國藥新冠疫苗列入緊急使用清單。
晨鳴紙業漲近4%,據報道,過去一年間,美國衛生紙價格上漲了15.6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.